Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 21, 2015 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Announces Positive Top-Line Results From a Pivotal Phase 3 Study for Abuse-Deterrent Opioid ELI-200

NORTHVALE, N.J., Oct. 21, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today announced positive top-line results from the Phase 3 pivotal trial of...
September 02, 2015 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals to Present at the 17th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th

NORTHVALE, N.J., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCQB:ELTP) a specialty pharmaceutical company which manufactures and sells niche generic products and is developing a...
August 10, 2015 16:19 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Record Revenues for First Quarter of Fiscal Year 2016

NORTHVALE, N.J., Aug. 10, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), announced results for the quarter ended June 30, 2015, the first quarter of its...
August 06, 2015 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss 1st Quarter 2016 Financial Results on August 11, 2015

NORTHVALE, N.J., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
August 03, 2015 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Completes Enrollment and Dosing for ELI-200 Phase III Efficacy Trial

NORTHVALE, N.J., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), today announced the completion of patient enrollment and dosing for the Phase III...
June 16, 2015 10:33 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology

NORTHVALE, N.J., June 16, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the issuance of U.S. Patent No. 9,056,054 entitled...
June 15, 2015 16:58 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2015

Elite Pharmaceuticals Reports Nine Percent Revenue Growth Webcast and Conference Call Scheduled for Tuesday, June 16 at 11:00 AM EDT NORTHVALE, N.J., June 15, 2015 (GLOBE NEWSWIRE) -- Elite...
June 11, 2015 18:24 ET | Source: Elite Pharmaceuticals, Inc.

CORRECTION -- Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss Year End 2015 Financial Results on June 16, 2015

NORTHVALE, N.J., June 11, 2015 (GLOBE NEWSWIRE) -- In the press release issued earlier today by Elite Pharmaceuticals, Inc. (OTCQB:ELTP) with the same headline, please note that the conference call...
June 11, 2015 16:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss Year End 2015 Financial Results on June 16, 2015

NORTHVALE, N.J., June 11, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
June 09, 2015 08:00 ET | Source: Elite Pharmaceuticals, Inc.

Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200

NORTHVALE, N.J., June 9, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP) announced today that it has entered into a sales and distribution licensing...